CME Activities

Conference Details

Return to Search

Sixth Annual Structural Heart Disease Conference: Valvular, Non-Valvular, and Congenital Interventions

6/1/2018 - 6/1/2018
Dr. Aimee Armstrong      Dr. Sitaramesh Emani      Dr. Shraddha Mainali     
Dr. Darren Berman      Dr. Antolin Flores      Ms. Susan O'Neil     
Dr. Sujatha Bhandary      Mr. Matthew Granger      Dr. David Orsinelli     
Dr. Brian Boe      Dr. John Hummel      Dr. Gregory Rushing     
Dr. Konstantinos Boudoulas      Dr. Rami Kahwash      Dr. Thomas Ryan     
Dr. Curt Daniels      Dr. Scott Lilly      Dr. Bryan Whitson     
Prof. Lakshmi Dasi      Dr. Brian Lindman      Ms. Janet Wyman
Ms. Jennifer Dollery     
The Ohio State University Wexner Medical Center
170 Davis Heart and Lung Research Institute
473 W. 12th Avenue
Columbus, OH

At the conclusion of this activity, participants should be able to:

1. Describe the characterization of aortic stenosis, the timing of referral, and the options for aortic valve replacement;
2.  Discuss the classification of mitral valve regurgitation, how to medically optimize these patients, and device-based options for mitral valve disease;
3.  Discuss the importance of multidisciplinary structural heart and congenital heart disease teams;
4.  Identify patients that will benefit from tricuspid valve interventions;
5.  Recognized the population of patients that stand to benefit from left atrial appendage closure;
6.  Discuss emerging strategies for treating diastolic heart failure;
7.  Describe the anatomy of septal defects, and indications for closure;
8.  Review the management of adults with coarctation of aorta and the necessity and timing for intervention.

Heart failure and cardiomyopathy are direct results of valvular heart disease.  Heart failure management is challenging in patients with structural heart disease.  As more patients develop degenerative structural heart disease, it is important for local cardiologists and heart failure specialists to understand when patients are appropriate for referral or intervention.  The development of a collaborative team effort amongst all clinical areas is essential.  Individuals with congenital heart disease are surviving longer than before.  Accordingly, many adult cardiologists are faced with the management of congenital heart conditions.  One endeavor of this CME activity is to improve the overall knowledge concerning device based therapies for adult congenital heart disease - from indications to timing to device selection.
Type Price
Physician $50.00
Nurse, Nurse Practitioner $25.00
Allied Medical Professional $25.00
Ellen Yokoyama
Davis Heart and Lung Research Institute
Additional Information


Sixth Annual  Structural Heart Disease Conference: Valvular, Non-Valvular and Congenital Interventions

The Ohio State University 
Davis Heart and Lung Research Institute Auditorium
473 W. 12th Ave.
Columbus, Ohio 43210

7:15 a.m.   Registration and Breakfast

7:45 a.m.        Introduction and Open Remark
8:00 a.m.        Aortic Stenosis: The Details are in the Diagnostics! 
                        Brian Lindman, MD
8:30 a.m.        The Data that Transformed Aortic Valve Replacement
                        Gregory Rushing, MD
8:45 a.m.        The Valve is In, Now What?  Durability, Short- and Long-term

                        Lakshmi Dasi, PhD
9:15 a.m.        Expanding Therapies and Populations for Aortic Valve Disease
                        Scott Lilly, MD, PhD

10:00 a.m.      Break

10:15 a.m.      Mitral Regurgitation: The Fundamentals of Classification
                        David Orsinelli, MD
11:00 a.m.      Optimization of the Patient with Mitral Valve Disease
                        Sitaramesh Emani, MD
11:15 a.m.      A Surgeon’s View: Ideal Patient Outcomes with Surgical Mitral Valve

                        Bryan Whitson, MD, PhD
11:30 a.m.      An Interventionist’s View: Ideal Patient and Outcomes with Transcatheter 
                       Mitral Valve Therapies 

                        Konstantinos Dean Boudoulas, MD
11:45 a.m.      A Case-based Approach to Mitral Valve Therapies: Navigating
                       Options –Panel 

12:15 p.m.      Lunch

Breakout Sessions A, B, C, D

Breakout Session A:
1:15 p.m.      The Adult Congenital Heart Disease Team
                        Matthew Granger, MS, CNP, FNP-BC
1:30 p.m.      Efficiencies in a Growing Structural Heart Disease Program
                        Janet Wyman, MSN, APRN, BC, CNP
1:45 p.m.      Local Testing for the Structural Heart Disease Patient
                        Jennifer Dollery, BSN and Susan O’Neil, MSN,APRN-CNP

Breakout Session B:
1:15 p.m.      Outlook for Tricuspid  Valve Therapies
                        Satya Shreenivas, MD 
1:30 p.m.      The Rationale for Left Atrial Appendage Closure
                        John Hummel, MD
1:45 p.m.      IntraCardiac Shunts for the Heart Failure Patients
                        Rami Kahwash, MD

Breakout Session C:
1:15 p.m.      A Neurologist’s Perspective on Patent Foramen Oval Closure
                        Vivien Lee, MD
1:30 p.m.      Behind the Curtain: Hemodynamic Considerations During Valve Procedures 
                        Antolin Flores, MD
1:45 p.m.      Wake Up! Advances in the Anesthetic Care of the Structural Heart Patient
                        Sujatha Bhandary, MD

Breakout Session D:
1:15 P.M.      Cardiac Anatomy: A Hands on Walk-through
                        Darren Berman, MD

2:00 p.m.      Break (Return to Auditorium)

2:15 p.m.     Adult Congenital Heart Disease Population and Need for Intervention
                        Curt Daniels, MD
2:45 p.m.     The Lost Art of Right Heart Catheterization and When to Close Atrial Septal 
                    Defects and Patent Foramen Ovales

                        Brian Boe, MD
3:25 p.m.     Interventions for Coarctation of the Aorta
                        Darren Berman, MD
3:45 p.m.     Transcatheter Pulmonary Valve Replacement
                        Aimee Armstrong, MD
4:15 p.m.     Adjourn, Closing Remarks

4:30 p.m.     Hybrid and Research Lab tours 

6:00 p.m.     Reception and Dinner at the Ohio Stadium (RESERVATION REQUIRED)
                   411 Woody Hayes Dr. Columbus, Ohio 43210
6:30 p.m.     Dinner
6:45 p.m.     Keynote Lecture: Update on Valvular Heart Disease
                        Thomas Ryan, MD
7:45 p.m.     Adjournment and tour of the Stadium

Accreditation Statement

The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University Center for Continuing Medical Education (CCME) designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Downloadable Files
to view PDF Brochures download Adobe Reader
My CCME Account
CCME Username
Your username is an email address
Forgot Your Password?
Search CCME